Secondary angiosarcoma of the breast is a rare, but well‐described complication of radiation therapy for primary breast carcinoma. Currently, it appears refractory to most systemic chemotherapy though rare responses to taxanes exist. Overall, patient prognosis is poor.
Publications
Refractory angiosarcoma of the breast with VEGFR2 upregulation successfully treated with Sunitinib: A case report and review of 7 additional cases with molecular profiling
– Caris Life Sciences
Read the Full Manuscript